Versatile Affielisa® Human Complement C1q Tumor Necrosis Factor-related Protein 3 Elisa [ C1qtnf3] Device [sZ8b5li6]

AffiELISA® Human Complement C1q tumor necrosis factor-related protein 3 ELISA [C1QTNF3]

The AffiELISA® Human Complement C1q tumor necrosis factor-related protein 3 ELISA [C1QTNF3] is a high-quality, ready-to-use assay kit designed for the quantitative measurement of C1QTNF3 in various biological samples. This kit offers a reliable and efficient method for researchers to study the role of C1QTNF3 in human health and disease. With its exceptional sensitivity and specificity, this ELISA kit is an invaluable tool for clinical diagnostics, drug discovery, and basic research.

Product Features and Specifications

The AffiELISA® Human Complement C1q tumor necrosis factor-related protein 3 ELISA [C1QTNF3] is equipped with a unique set of features that make it stand out from other similar products. Here are some of its key benefits:

• High Sensitivity: The kit is designed to detect low levels of C1QTNF3 with exceptional sensitivity, ensuring accurate and reliable results.
• Specificity: The use of specific antibodies guarantees minimal cross-reactivity, providing precise measurements of C1QTNF3 levels.
• Easy to Use: The kit comes with comprehensive instructions and all necessary reagents, making it easy to perform the assay without the need for specialized equipment.
• Robust Performance: The kit has been rigorously tested and validated, ensuring consistent and reproducible results across various sample types and concentrations.

Practical Uses and Applications

The AffiELISA® Human Complement C1q tumor necrosis factor-related protein 3 ELISA [C1QTNF3] is widely applicable in various research fields. Its practical uses include:

• Research on Inflammation: C1QTNF3 is known to play a crucial role in the inflammatory response. This kit can help researchers study the impact of C1QTNF3 in inflammatory diseases.
• Diagnosis of Autoimmune Diseases: C1QTNF3 levels are often altered in autoimmune diseases. This kit can be used to diagnose and monitor these conditions.
• Drug Discovery: The ability to accurately measure C1QTNF3 levels can aid in the development of new therapeutic agents targeting this protein.